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Background: Sickle cell nephropathy (SCN) is an important cause of mortality in patients with
sickle cell disease. SCA with systemic lupus erythematosus (SLE) is known in children and less
common in adults, however diffuse proliferative lupus nephritis (DPLN) with SCN has rarely been
reported in adults. It requires early diagnosis and aggressive management.
Case presentation: We present here a 35 years old lady with sickle cell disease who presented
with edema, dyspnoea on exertion, pyuria and had raised s. creatinine of 7 mg%. Her biopsy
revealed SCN with DPLN. She is on maintenance hemodialysis after 2 months of diagnosis.
Conclusion: DPLN with SCN is a rare entity with poor prognosis, which may be overlooked and
needs aggressive management.
Introduction
Sickle cell nephropathy (SCN) is an important cause of
mortality in patients with sickle cell disease (SCD) [1].
SCN includes hematuria, papillary necrosis, urinary con-
centrating defect, impaired renal acidification and potas-
sium excretion, supranormal proximal tubular function,
proteinuria, and renal failure1. Incidence of renal failure
in SCD ranges from 5 to 18% [2]. SCN associated with dif-
fuse proliferative lupus nephritis (DPLN) is a rare entity.
We present here a 35 year old lady with sickle cell disease
(SCD) and DPLN.
Case presentation
A 35 year old female with SCD, presented with pedal and
periorbital edema, distension of abdomen, decreased
urine output and dyspnoea on exertion since 1 month.
On examination, she was pale, with pulse rate of 100/
minute, normal temperature, and blood pressure was
160/100 mm Hg. Her abdomen was distended due to
moderate ascites however there was no organomegaly/
scars. Cardio-respiratory and neurological examination
was unremarkable. Ultrasonography showed right kidney,
10.9 × 6.0 cm, left kidney of 11.4 × 5.8 cm, with increased
echogenicity and maintained cortico-medullary differen-
tiation. Moderate ascites was present.
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On investigations, urine albumin was 500 mg/24 hours,
microscopy showed 30–40 pus cells and 3–5 granular
casts/high power field, urine culture was sterile, serum cre-
atinine, 7.0 mg%, serum proteins, 4.5 gm/dL; serum albu-
min, 1.8 gm%, serum bilirubin was 0.5 mg/dL, serum
alanine amino transferase was 16 units/L, random blood
sugar was 87 mg/dL, serum uric acid was 7.5 mg/dL,
serum sodium was 134 meq/L and serum potassium, 5.5
meq/L and positive sickling test was noted at 24 hours.
Her hemoglobin was 7.1 gm/dL; total leucocyte count was
7,700/cmm with differential count showing neutrophils,
76%, lymphocytes, 20% and eosinophils and monocytes,
each, 2%. Peripheral smear showed few crenated and sick-
led cells with mild hypochromia and anisopoikylocytosis.
She was dialyzed and 2 units of packed cells were trans-
fused. Renal biopsy was performed and after paraffin
embedding, 3 micrometer sections were taken and stained
using Hematoxylin and eosin, Periodic Acid Schiff, Jone's
silver methaneamine and Gomori's trichrome stains. Indi-
rect immunofluorescence studies were performed using
anti-human IgG, IgM, IgA, C1q, C3, albumin and fibrino-
gen anti-sera (DAKO, USA). Histopathology revealed one
core with 13 glomeruli. All of them were moderately
enlarged in size and 11 had exuberant and occasionally
circumferential cellular (rarely fibrocellular) crescents
occupying 70–90% urinary spaces, occasionally replacing
capillary tufts and shrinking or pushing the capillary tufts
towards vascular poles (Figure 1). Capillary tufts had
fairly open lumina lined by membranes with occasional
reduplication, thickening/rupture. There was uniform
moderate mesangial prominence. Capillaries and cres-
cents were infiltrated by few sickle shaped, dysmorphic
RBCs, platelet/fibrin thrombi. Afferent and efferent arteri-
oles were filled with sickled RBCs. Bowman capsules were
segmentally thickened and occasionally ruptured evoking
periglomerular leucocytic reaction. Tubules were moder-
ately degenerated and filled with cellular casts and rarely
RBCs. Focal atrophy was also evident. Interstitium was
moderately prominent for focal fibrosis and overlying
focal mononuclear cellular infiltration with admixed neu-
trophils. Peri-tubular capillaries were dilated and filled
with sickled RBCs (Figure 2). At least one medium caliber
and two small caliber arteries showed lumina filled with
trapped dysmorphic RBCs.
Immunofluorescence studies showed fine granular fluo-
rescence (+2) across 60–80% mesangial regions and adja-
cent capillaries of all glomeruli on staining with anti-
human C3 and (trace/+1) with anti-human IgG, C1q and
fibrinogen antisera (Figure 3). Subsequently she was
investigated for vasculitis and lupus nephritis. Indirect
immunofluorescence and ELISA revealed anti-nuclear
antibodies, (normal index: <1, test: 8.5), anti-dsDNA anti-
bodies were >200 IU/mL (normal <25 IU/mL, Orgentec,
Germany). Anti-neutrophil cytoplasmic antibodies were
absent. Final diagnosis was made as SCN with DPLN, ISN/
RPS class IV-G (A).
Hemoglobin variant study using High Performance Liq-
uid Chromatography (d-10, Biorad, USA) was performed
5 days after transfusion which showed HbSA of 6.9% (Fig-
ure 4).
She was treated with Methylprednisolone 500 mg, intra-
venously for 3 days and Cyclophosphamide, 500 mg
intravenously immediately and dose was repeated after 21
Dilated peri-tubular capillaries filled with sickled RBCs, origi- nal Gomori's trichrome stain, × 400 Figure 2
Dilated peri-tubular capillaries filled with sickled RBCs, origi-
nal Gomori's trichrome stain, × 400.
One glomerulus with circumferential cellular crescent and  diffuse endocapillary proliferation infiltrated with few leuco- cytes and RBCs, and surrounded by focally atrophied or  moderately degenerated tubules Figure 1
One glomerulus with circumferential cellular crescent and 
diffuse endocapillary proliferation infiltrated with few leuco-
cytes and RBCs, and surrounded by focally atrophied or 
moderately degenerated tubules. Diffuse leucocytic infiltra-
tion in parenchyma noted; Hematoxylin and eosin stain, × 
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days. Then she was switched over to oral Prednisolone, 40
mg/day. Hemodialysis was done on alternate days for 21
days. At follow-up of 2 months, she is on maintenance
dialysis with urine output of less than 400 ml/day.
Discussion
Patients with SCA are known to develop idiopathic neph-
rotic syndrome with focal and segmental glomeruloscle-
rosis or with membranoproliferative glomerulonephritis.
Systemic lupus erythematosus (SLE) has been reported in
adults and more frequently in children with SCD [3,4].
However lupus nephritis with SCN has been rarely docu-
mented in adults. It is postulated that a defect in the alter-
nate pathway of complement activity seen in patients with
SCD may predispose to immune complex disorders [5].
There are broad spectrum of systemic complications asso-
ciated with SCD and/or SLE [6,7]. Mesangial expansion,
basement membrane duplication as well as occurrence of
immune complex disorders in SCD may delay the
unmasking of lesion due to SLE unless serological work-
up is done. This is a rare case of DPLN along with SCN in
an adult, who has become dialysis dependent.
Conclusion
SCN with DPLN is a rare clinico-pathologic entity which
requires timely diagnosis and aggressive management.
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Haemoglobin variant study suggestive of HbSA Figure 4
Haemoglobin variant study suggestive of HbSA.
Immunofluorescence study showing anti-human C3 deposi- tion in mesangium and occasional capillaries of glomerulus Figure 3
Immunofluorescence study showing anti-human C3 deposi-
tion in mesangium and occasional capillaries of glomerulus.Publish with BioMed Central    and   every 
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